Full Text
PCN32 RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY (CRC)

Abstract

Authors

FK Kokkotos RA Bailey M Kerr S Shen M Senbetta RS McKenzie

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×